Biopsy X · Endodrill® Model X - a new endoscopic biopsy instrument taking multiple cancer samples of varying depth in one single session

The overall objective of this 6-month Phase 1 project is to evolve the prototype of Biopsy X, the new reliable endoscopic biopsy instrument, taking multiple cancer samples of varying depth in one single session, to transform our initial business plan into a robust strategy for international commercialization and to prepare for a Phase 2 demonstration. Our product is the missing link that will bring effective, fast and patient-friendly cancer diagnosis, setting up the new standard for this method. The EndoDrill® Model X is a unique combination of knowledge in mechanical engineering, physics and physiology. Research has been partially funded by Swedish R&D grants from Vinnova as well as from foundations (Sten K Jonsson Foundation, IKEA Foundation) and Lund University Innovation. Since 2017 the company is listed at AktieTorget stock market.Our ambition is to accelerate proper diagnosis progress so that 3 in 4 people will survive cancer within the next 20 years by making sure patients have access to the best, fastest, safe and characterized with ultra-high precision cancer diagnostic method, minimizing at the same time the level of discomfort. BiBBInstruments AB is well-positioned to bring its innovation to the market. The product has been developed and validated by practitioners in close cooperation with Skåne University Hospital in Lund as well as by end-users. This has assured market proximity of all the R&D activities.